Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer
To access this article, please choose from the options below
PII: S0720-048X(08)00593-7
doi:10.1016/j.ejrad.2008.10.031
© 2009 Published by Elsevier Inc.
